Annual Drug Patent Expirations for PHOSLO
Phoslo is a drug marketed by Fresenius Medcl and is included in two NDAs. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for PHOSLO.
The generic ingredient in PHOSLO is calcium acetate. Three suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
